Table 1.

Pneumococcal vaccination rates^a among ’every year‘ patients aged 60–65 years in 2010 (at least one consultation per year from 2010 to 2017), according to patient and practice’s characteristics. Results from cohort data analysis (n = 58,549). Australia, 2010–2017.

Variable	Sample distribution (%)	Proportion of vaccinated (%, 95%CI)	p-value
Practice’s Characteristics
Rurality			< 0.0001
Major cities	56.2	68.5 (68.0;69.1)
Inner regional	31.1	69.7 (69.0;70.4)
Outer regional/Remote/Very remote	12.8	66.2 (64.9;67.4)
IRSAD Quintile			< 0.0001
Very high	11.7	69.8 (68.7;71.0)
High	27.2	65.4 (64.6;66.2)
Middle	19.9	68.7 (67.8;69.6)
Low	21.0	68.9 (68.1;69.7)
Very Low	20.2	71.7 (70.8;72.5)
Patient’s Characteristics
Gender			0.0051
Male	43.5	68.0 (67.4;68.6)
Female	56.5	69.1 (68.6;69.6)
IRSAD quintile			0.1444
Very high	22.0	67.7 (66.5;68.9)
High	16.2	67.7 (66.7;68.8)
Middle	24.1	69.4 (68.5;70.3)
Low	17.9	68.9 (68.0;69.9)
Very Low	19.8	69.1 (68.0;70.2)
Comorbiditiesb			< 0.0001
No	42.6	64.4 (63.8;65.0)
Yes	57.4	71.8 (71.3;72.3)
Smoking status			< 0.0001
Non smoker	53.5	68.2 (67.7;68.7)
Smoker	6.9	64.9 (63.4;66.3)
Ex smoker	35.6	71.2 (70.6;71.8)
Not recorded	4.1	57.4 (55.4;59.4)

^aAnalyses of practice’s characteristics are adjusted for each other and median yearly consultations; analyses of patient’s characteristics are adjusted for gender, practice’s characteristics and median yearly consultations.

^bComorbidities include: cardiac disease, chronic neurological disease, chronic respiratory disease, chronic liver disease, immunocompromising conditions or other chronic diseases (including chronic renal failure, diabetes mellitus or hemoglobinopathies).